A first-in-human, phase I/IIa trial of the T cell immunotherapy personalised tumour trained lymphocytes in patients with advanced colorectal cancer: Study protocol
Ahmed Tarfy, Andrea Salmén, Guro Gafvelin, Hans Grönlund, Abbas Chabok, Maziar Nikberg, Per J Nilsson, Mattias Carlsten · 2026
Read A first-in-human, phase I/IIa trial of the T cell immunotherapy personalised tumour trained lymphocytes in patients with advanced colorectal cancer: Study protocol by Ahmed Tarfy, Andrea Salmén, Guro Gafvelin, Hans Grönlund, Abbas Chabok, Maziar Nikberg, Per J Nilsson, Mattias Carlsten (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0351697.txt.
Description
Ahmed Tarfy leads a team of eight publishing the protocol for a first in human trial of a personalized cell therapy in advanced colorectal cancer, in PLOS ONE in 2026. The treatment harvests T cells from the lymph nodes that drain a patient's tumor. Those nodes have already met the cancer. Their cells can be trained in the laboratory against the patient's own tumor mutations. Sequencing and prediction software select the targets. The trained cells return as a living drug.
The trial unfolds in three parts: collecting nodes and manufacturing the cells, a single infusion after immune conditioning chemotherapy, and follow up stretching to five years. Up to sixteen patients with stage four disease can join. Being a protocol, the paper promises no results; its value is transparency about how a bespoke therapy is built and judged. Safety at this stage outranks cure, and the staged design reflects that caution.
Catalog record
| CREATOR | Ahmed Tarfy, Andrea Salmén, Guro Gafvelin, Hans Grönlund, Abbas Chabok, Maziar Nikberg, Per J Nilsson, Mattias Carlsten |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41270 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |